![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Utilization and Effectiveness of Elbasvir/Grazoprevir for
the Treatment of Hepatitis C Virus Genotype 1b Infection:
Updated Cohort From the US Veteran Affairs Healthcare System
|
|
|
Reported by Jules Levin
AASLD 2018 Nov 9-12 Boston
Amy Puenpatom1; Jennifer R. Kramer2,3; Yumei Cao2; Hashem El-Serag2,3; Roshani Shah1;
Fashiha Kanwal2,3
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Michael E. DeBakey VA Medical Center, Houston, TX, USA;
3Baylor College of Medicine, Houston, TX, USA
![1114181](../images%20/111418/111418-7/1114181.gif)
![1114182](../images%20/111418/111418-7/1114182.gif)
![1114183](../images%20/111418/111418-7/1114183.gif)
![1114184](../images%20/111418/111418-7/1114184.gif)
![1114185](../images%20/111418/111418-7/1114185.gif)
![1114186](../images%20/111418/111418-7/1114186.gif)
![1114187](../images%20/111418/111418-7/1114187.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|